Cancer Treatments

International clinical trial exploring treatment combinations for rare and aggressive cancers in women launched in Australia

Vaccination given in combination with autologous stem cell transplant was associated with long-term disease control

The safety profile of cabozantinib observed in the trial was consistent with its known safety profile

Pan-cancer dataset built from multiomic analyses and proteomic studies is publicly available for global use

Dinutuximab beta therapy augments stem cell transplantation in patients with neuroblastoma

Monotherapy with new PRMT5 inhibitor well tolerated with low toxicity in adults with B cell non-Hodgkin lymphomas 

Combination therapy improved median disease-free and overall survival in pancreatic ductal adenocarcinoma cases

Can modeling the complexities of disease using organ-on-a-chip platforms help improve cancer therapies?

ComboMATCH comprises several Phase 2 treatment trials that will each evaluate a drug combination plus a chemotherapy drug